NASDAQ:MLAB - Mesa Laboratories Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$209.00 +0.04 (+0.02 %)
(As of 07/22/2018 10:21 AM ET)
Previous Close$209.00
Today's Range$206.51 - $211.96
52-Week Range$122.35 - $224.95
Volume9,593 shs
Average Volume22,018 shs
Market Capitalization$795.96 million
P/E Ratio33.82
Dividend Yield0.31%
Beta0.45
Mesa Laboratories logoMesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. Its Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes; and cleaning indicators, which are used to assess the effectiveness of cleaning processes. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments; parameter monitoring services for products in a cold chain; and consulting services. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
SymbolNASDAQ:MLAB
CUSIP59064R10
Phone303-987-8000

Debt

Debt-to-Equity Ratio0.45
Current Ratio1.85
Quick Ratio1.32

Price-To-Earnings

Trailing P/E Ratio33.82
Forward P/E Ratio30.56
P/E GrowthN/A

Sales & Book Value

Annual Sales$96.18 million
Price / Sales8.28
Cash Flow$8.6866 per share
Price / Cash24.06
Book Value$26.26 per share
Price / Book7.96

Profitability

EPS (Most Recent Fiscal Year)$6.18
Net Income$-2,960,000.00
Net Margins-3.08%
Return on Equity12.93%
Return on Assets7.66%

Miscellaneous

Employees366
Outstanding Shares3,810,000
Market Cap$795.96

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Monday, July 9th. Stockholders of record on Friday, August 31st will be given a dividend of $0.16 per share on Monday, September 17th. This represents a $0.64 annualized dividend and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, August 30th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) posted its quarterly earnings data on Tuesday, June, 5th. The medical instruments supplier reported $1.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.24. The medical instruments supplier earned $26.88 million during the quarter, compared to the consensus estimate of $25.40 million. Mesa Laboratories had a positive return on equity of 12.93% and a negative net margin of 3.08%. View Mesa Laboratories' Earnings History.

What is the consensus analysts' recommendation for Mesa Laboratories?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Mesa Laboratories' key competitors?

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 50)
  • Mr. John V. Sakys, Chief Financial & Chief Accounting Officer, Sec. and Treasurer (Age 49)
  • Mr. Gregory DiNoia, Sr. VP of Commercial Operations (Age 53)
  • Ms. Helene R. Leone, Gen. Counsel
  • Mr. Peter Jung, VP of Corp. Devel. & Strategy

Has Mesa Laboratories been receiving favorable news coverage?

News headlines about MLAB stock have trended somewhat positive on Sunday, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mesa Laboratories earned a media sentiment score of 0.07 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (11.25%) and Kistler Tiffany Companies LLC (0.04%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Kistler Tiffany Companies LLC. Company insiders that have sold Mesa Laboratories company stock in the last year include H Stuart Campbell, John Bradley Schmieder, John James Sullivan and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was purchased by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $209.00.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $795.96 million and generates $96.18 million in revenue each year. The medical instruments supplier earns $-2,960,000.00 in net income (profit) each year or $6.18 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]


MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  245
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.